HD-OPM Archive
Topics › Kidney health

Gut-bacteria peptide corisin drives diabetic kidney fibrosis in mice

Gokhan Can · Aug 26, 2025 · ♥ 8 reactions · 1 comments · original Facebook post
Kidney healthGut microbiomeInsulin resistance & diabetes
AI summary & key facts

A study found the gut-bacteria peptide corisin is elevated in diabetic patients with CKD and tracks with severity. In mice, corisin travels to the kidney on albumin and accelerates aging, scarring and cell death, and a neutralizing antibody reduced kidney damage. Gokhan notes CKD almost always accompanies heart disease.

Sounds like great progress was made with chronic kidney disease. Chronic kidney disease almost always accompanies heart disease.


This study reveals that corisin, a peptide produced by gut bacteria, plays a significant role in the progression of diabetic kidney fibrosis. Researchers found elevated levels of corisin in the blood of diabetic patients with chronic kidney disease, which correlated with the severity of their condition and declining kidney function. The study demonstrates that corisin travels to the kidneys by binding to serum albumin and once there, it accelerates cellular aging, promotes harmful cellular transitions, and induces cell death, all of which worsen kidney fibrosis. Importantly, in a mouse model of the disease, treatment with a monoclonal antibody that neutralizes corisin was shown to significantly reduce the severity of the kidney damage, suggesting that targeting corisin could be a promising new therapeutic strategy for diabetic nephropathy.

share.googleLink to share.googleA molecule made by bacteria in the gut can hitch a ride to the kidneys, where it sets off a chain reaction of inflammation, scarring and fibrosis—a serious complication of diabetes and a leading cause of kidney failure—according to a new study from researchers at the University of Illinois Urban...share.google

Research cited

#kidneys#peptides#heartdisease#mice#aging
← newer: Treating gum disease slows carotid artery thickening in a clolder: Doctor's path to halving ApoB and triglycerides with rosuvas →